Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 54 pages
Exam (elaborations)

PHARMACY IMMUNIZATION TECHNICIAN EXAM PREP 2026 Updated Practice Questions Comprehensive Vaccine Administration Review Detailed Explanations | Verified Answers | Success Workbook

Document preview thumbnail
Preview 4 out of 54 pages

PHARMACY IMMUNIZATION TECHNICIAN EXAM PREP 2026 Updated Practice Questions Comprehensive Vaccine Administration Review Detailed Explanations | Verified Answers | Success Workbook

Content preview

PHARMACY IMMUNIZATION TECHNICIAN EXAM
PREP 2026 Updated Practice Questions Comprehensive
Vaccine Administration Review Detailed Explanations |
Verified Answers | Success Workbook

QUESTION 1:
Which type of immunity results from natural infection or vaccination where the
body produces its own antibodies?
A) Passive immunity
B) Active immunity
C) Innate immunity
D) Herd immunity


Answer: B) Active immunity
Rationale: Active immunity occurs when the body's immune system produces its
own antibodies in response to an antigen, either from natural infection or
vaccination. This type of immunity provides long-lasting protection through
immunological memory. Passive immunity, in contrast, involves receiving pre-
formed antibodies (e.g., from maternal transfer or immunoglobulin therapy) and
provides only temporary protection. Innate immunity is the body's non-specific
first line of defense, while herd immunity describes population-level protection
when a sufficient proportion of the community is immune.


QUESTION 2:
What is the primary mechanism of action of vaccines?
A) Directly killing pathogens in the body
B) Stimulating the immune system to produce a protective response
C) Blocking pathogen entry at mucosal surfaces
D) Providing immediate passive antibodies


Answer: B) Stimulating the immune system to produce a protective response

,Rationale: Vaccines work by stimulating the immune system to recognize and
respond to specific pathogens. They contain antigens that mimic disease-causing
organisms but do not cause the disease itself. This triggers the production of
antibodies and memory cells, providing protection against future exposure.
Vaccines do not directly kill pathogens, block entry, or provide passive immunity.


QUESTION 3:
Which vaccine classification contains live, attenuated (weakened) organisms?
A) Inactivated vaccines
B) Subunit vaccines
C) Live-attenuated vaccines
D) Toxoid vaccines


Answer: C) Live-attenuated vaccines
Rationale: Live-attenuated vaccines contain weakened (attenuated) forms of the
pathogen that can replicate in the body without causing disease. Examples include
MMR (measles, mumps, rubella), varicella (chickenpox), and live attenuated
influenza vaccine (LAIV). These vaccines typically produce strong, long-lasting
immunity but are contraindicated in immunocompromised individuals. Inactivated
vaccines contain killed pathogens, subunit vaccines contain only parts of the
pathogen, and toxoid vaccines contain inactivated toxins.


QUESTION 4:
Pregnant women should NOT receive which type of vaccine?
A) Inactivated influenza vaccine
B) Tdap vaccine
C) Live-attenuated vaccines
D) COVID-19 vaccines


Answer: C) Live-attenuated vaccines

,Rationale: Live-attenuated vaccines (such as MMR, varicella, and LAIV) are
generally contraindicated during pregnancy due to the theoretical risk of
transmission to the fetus. The live virus could potentially cross the placenta and
cause fetal infection. Inactivated vaccines, including influenza, Tdap, and COVID-
19 vaccines, are generally considered safe and are recommended during pregnancy
to protect both the mother and infant.


QUESTION 5:
What is the role of an adjuvant in a vaccine?
A) To kill the pathogen
B) To enhance the immune response to the antigen
C) To preserve the vaccine
D) To stabilize the vaccine formulation


Answer: B) To enhance the immune response to the antigen
Rationale: Adjuvants are substances added to vaccines to enhance the body's
immune response to the antigen. They help create a stronger and longer-lasting
immune response, allowing for lower doses of antigen and fewer doses needed for
protection. Common adjuvants include aluminum salts, MF59, and AS01.
Adjuvants do not kill pathogens, preserve vaccines, or provide primary
stabilization (though they may contribute to formulation stability).


QUESTION 6:
Which of the following best describes herd immunity?
A) Immunity acquired through vaccination of the individual
B) Protection of a population when a sufficient proportion is immune
C) Immunity passed from mother to infant
D) Immunity from natural infection


Answer: B) Protection of a population when a sufficient proportion is immune

, Rationale: Herd immunity (or community immunity) occurs when a sufficient
proportion of a population is immune to a disease, making it difficult for the
disease to spread. This provides indirect protection to those who are not immune,
including those who cannot be vaccinated for medical reasons. The threshold for
herd immunity varies by disease and its contagiousness. It is a population-level
concept, not individual immunity.


QUESTION 7:
What is the primary purpose of the Vaccine Information Statement (VIS)?
A) To document the vaccine lot number
B) To explain the benefits and risks of a vaccine to recipients
C) To provide billing information for the vaccine
D) To record the patient's vaccination history


Answer: B) To explain the benefits and risks of a vaccine to recipients
Rationale: Vaccine Information Statements (VISs) are information sheets
produced by the CDC that explain both the benefits and risks of a vaccine to
vaccine recipients. Federal law requires that VISs be given to patients (or their
legal representatives) before each dose of certain vaccines. The VIS is part of the
informed consent process and helps patients make educated decisions about
vaccination. It is not a billing document or a vaccination record.


QUESTION 8:
What does "EUA" stand for in the context of vaccine administration?
A) Emergency Use Authorization
B) European Union Approval
C) End User Agreement
D) Extended Use Authorization


Answer: A) Emergency Use Authorization

Document information

Uploaded on
August 15, 2026
Number of pages
54
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$27.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Sold
10
Followers
0
Items
2429
Last sold
10 hours ago


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions